Intelligence / Healthtech / FDA 510(k) Clearances / Brixton Biosciences
Approvalsdevice cleared21 Aug 2026
Brixton Biosciences
21 Aug 2026: Device cleared · ReneuRx (Neural Ice). Recorded in the openFDA device 510(k) data.
- Decided
- 21 Aug 2026
- Device
- ReneuRx (Neural Ice)
- Specialty
- Orthopedic
- Country
- United States
- Location
- Cambridge, MA
- Clearance type
- Direct
- 510(k) number
- DEN250067
- Submitted
- 2025-12-15
What this signal means
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS
Find the decision makers at Brixton Biosciences
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Brixton Biosciences in our registers.
More in Orthopedic
FDA 510(k) Clearances
6 NovSolco Biomedical Company India Private Limiteddevice cleared · 4CIS BLUE DOLPHIN CAGE SYSTEMApprovals5 NovFX Shoulder Solutions, Inc.device cleared · Easytech Reversed Shoulder SystemApprovals5 NovOnkos Surgical, Inc.device cleared · ELEOS with NanoCept® Technology Limb Salvage SystemApprovals5 NovSurgical Fusion Technologies GmbHdevice cleared · SF Push-in AnchorApprovals2 NovGM Dos Reis Industria e Comercio Ltda.device cleared · DuoCore Non-Compressive IM NailApprovals2 NovHero Orthopedics, LLCdevice cleared · HERO Sternal Closure SystemApprovals
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.